Supplement "general" references to bodily function should be disease claims -- Gilhooley.
This article was originally published in The Tan Sheet
Executive Summary
SUPPLEMENT "GENERAL FUNCTION" STATEMENTS INTERPRETATION AS DISEASE CLAIMS rather than structure/ function claims urged by Margaret Gilhooley, Seton Hall University, in a July 15 letter to FDA in response to the agency's recent proposed rule on structure/function claims. "In my view, a statement can be considered a disease claim even if it is not a specific reference to a disease or disease symptom," Gilhooley maintains. The Seton Hall law professor served as a member of the President's Commission on Dietary Supplement Labels.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: